Log In

Use of this portal is restricted to authorized medical office personnel. Please do not allow the private health information displayed within to be viewed by non-authorized third parties.

Welcome to the Co-Pay Savings Program Web Portal!
In-Office Injection

For patients who receive Cimzia® (certolizumab pegol) via in-office injection, the Cimzia Co-Pay Savings Program can help cover out of pocket costs. This portal allows your facility to enroll in the program, enroll your patients, and enter claims.

Click here to create an account or enter your Username and Password below:

Account Information

Username or Email Address

Password

Forgot Your Password?
Enter your Username or Email Address to receive your password.
Username or Email Address:

Practice Not Associated.


Please select a practice for the user.

Important Safety Information You Should Know About CIMZIA^®(certolizumab pegol). Serious and sometimes fatal side effects have been reported with CIMZIA, including tuberculosis (TB), bacterial sepsis, invasive fungal infections (such as histoplasmosis), and infections due to other opportunistic pathogens (such as Legionella or Listeria). Patients should be closely monitored for the signs and symptoms of infection during and after treatment with CIMZIA.
Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers, of which CIMZIA is a member. CIMZIA is not indicated for use in pediatric patients.
CIMZIA® is a registered trademark of the UCB Group of Companies. ©2021 UCB, Inc., Smyrna, GA 30080. All rights reserved. US-P-CZ-AS-2100044 Click to open full Safety Information Prescribing Information

Session Expired.